– USA, GA – Genuine Parts Company (NYSE: GPC) announced today that its Board of Directors elected Donna W. Hyland as a new independent Director of the Company. Ms. Hyland is President and Chief Executive Officer of Children’s Healthcare of Atlanta, one of the largest pediatric healthcare systems in the country. Previously, Ms. Hyland served Children’s as Chief Financial Officer from 1998 to 2002 and as Chief Operating Officer from 2003 to May 2008, when she was named President and CEO. In total, Ms. Hyland has 28 years of business leadership and financial experience and also serves on the board of Cousins Properties, Inc.
Tom Gallagher, Chairman and CEO of Genuine Parts Company, stated, “We are pleased to welcome Ms. Hyland as our newest director. Donna is an extremely talented executive with a wealth of business experience and knowledge that make her a valuable addition to our board. In addition, Donna’s extensive financial background qualifies her to sit on our audit committee as a financial expert. We look forward to her future contributions as a director of the Company.”
About Genuine Parts Company
Genuine Parts Company is a distributor of automotive replacement parts in the U.S., Canada, Mexico and Australasia. The Company also distributes industrial replacement parts in the U.S., Canada and Mexico through its Motion Industries subsidiary. S. P. Richards Company, the Office Products Group, distributes business products nationwide in the U.S. and Canada. The Electrical/Electronic Group, EIS, Inc., distributes electrical and electronic components throughout the U.S., Canada and Mexico. Genuine Parts Company had 2014 revenues of $15.3 billion.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
